金城医药
(300233)
| 流通市值：63.26亿 | | | 总市值：65.34亿 |
| 流通股本：3.72亿 | | | 总股本：3.84亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 853,676,725.38 | 917,670,953.09 | 891,290,168.1 | 1,074,172,826.25 |
| 衍生金融资产 | 106,330.01 | 107,044.84 | - | 484,934.3 |
| 应收票据及应收账款 | 569,068,495.94 | 591,766,131.11 | 506,821,358.6 | 551,913,216.36 |
| 其中：应收票据 | 51,960,111.27 | 21,234,288.54 | 25,628,805.29 | 24,568,883.62 |
| 应收账款 | 517,108,384.67 | 570,531,842.57 | 481,192,553.31 | 527,344,332.74 |
| 应收款项融资 | 120,382,243.01 | 105,029,422.47 | 116,444,922.93 | 90,713,000.84 |
| 预付款项 | 32,272,014.3 | 29,889,965.71 | 27,408,810.93 | 24,970,175.32 |
| 其他应收款合计 | 4,263,689.21 | 6,452,790.86 | 7,573,294.58 | 6,100,417.73 |
| 存货 | 596,359,058.41 | 598,863,558.41 | 599,987,796.19 | 542,626,810.41 |
| 其他流动资产 | 8,128,452.9 | 8,505,265.24 | 12,187,396.88 | 12,022,793.42 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,184,257,009.16 | 2,258,285,131.73 | 2,211,713,748.21 | 2,303,004,174.63 |
| 非流动资产: | | | | |
| 长期股权投资 | 19,083,664.73 | 18,669,447.79 | 18,660,782.73 | 18,590,606.69 |
| 其他权益工具投资 | 164,611,500.47 | 164,611,500.47 | 132,449,469.57 | 132,449,469.57 |
| 固定资产 | 2,169,602,168.58 | 2,228,579,550.89 | 2,276,166,095.8 | 2,318,856,812.4 |
| 在建工程 | 82,128,966.19 | 73,332,415.73 | 84,502,492.2 | 77,862,981.85 |
| 使用权资产 | 7,105,504.25 | 7,609,939.1 | 4,630,431.8 | 5,262,889.84 |
| 无形资产 | 495,343,765.6 | 513,508,542.87 | 515,202,837.74 | 517,968,374.65 |
| 开发支出 | 252,798,405.62 | 240,729,227.18 | 252,622,318.87 | 258,834,003.94 |
| 长期待摊费用 | 11,384,474.06 | 12,226,620.52 | 13,008,640.86 | 13,803,434.37 |
| 递延所得税资产 | 60,161,728.36 | 63,938,148.54 | 74,372,374.11 | 78,232,711.71 |
| 其他非流动资产 | 24,907,046.65 | 23,500,216.89 | 20,610,684.99 | 12,940,672.17 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,287,127,224.51 | 3,346,705,609.98 | 3,392,226,128.67 | 3,434,801,957.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,471,384,233.67 | 5,604,990,741.71 | 5,603,939,876.88 | 5,737,806,131.82 |
| 流动负债: | | | | |
| 短期借款 | 101,079,471.95 | 55,039,277.5 | 55,039,958.33 | 54,039,472.22 |
| 衍生金融负债 | - | - | 284,584.85 | - |
| 应付票据及应付账款 | 529,204,511.99 | 552,559,388.94 | 580,153,193.63 | 629,636,280.77 |
| 其中：应付票据 | 208,067,985.54 | 142,790,853.52 | 152,458,149.56 | 219,509,864.68 |
| 应付账款 | 321,136,526.45 | 409,768,535.42 | 427,695,044.07 | 410,126,416.09 |
| 合同负债 | 41,615,952.07 | 50,944,303.47 | 39,811,415.7 | 64,633,542.26 |
| 应付职工薪酬 | 153,144,787.82 | 206,271,864.19 | 192,930,058.79 | 173,207,222.4 |
| 应交税费 | 38,878,808.21 | 43,060,197.47 | 29,282,828.74 | 24,608,120.99 |
| 其他应付款合计 | 204,348,556.55 | 217,662,565.39 | 217,845,041.95 | 255,359,106.9 |
| 一年内到期的非流动负债 | 51,499,516.04 | 101,647,383.74 | 221,374,496.59 | 222,038,427.87 |
| 其他流动负债 | 3,117,197 | 3,789,955.34 | 3,266,967.15 | 5,325,337.28 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,122,888,801.63 | 1,230,974,936.04 | 1,339,988,545.73 | 1,428,847,510.69 |
| 非流动负债: | | | | |
| 长期借款 | 351,762,741.89 | 351,994,368.71 | 316,019,529.58 | 324,035,836.01 |
| 租赁负债 | 6,026,977.32 | 6,882,934.76 | 3,335,775.23 | 3,599,402.74 |
| 递延收益 | 51,429,942.37 | 53,879,464.75 | 57,125,389.19 | 57,374,635.25 |
| 递延所得税负债 | 125,848,072.36 | 129,104,883.44 | 125,446,185.36 | 128,454,533.93 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 535,067,733.94 | 541,861,651.66 | 501,926,879.36 | 513,464,407.93 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,657,956,535.57 | 1,772,836,587.7 | 1,841,915,425.09 | 1,942,311,918.62 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 383,874,587 | 383,874,587 | 383,874,587 | 383,874,587 |
| 资本公积 | 2,327,697,793.59 | 2,327,697,793.59 | 2,327,697,793.59 | 2,327,697,793.59 |
| 减:库存股 | 55,009,170 | 55,009,170 | 55,009,170 | 55,009,170 |
| 其他综合收益 | 53,352,942.02 | 53,352,942.02 | 30,084,361.77 | 30,084,361.77 |
| 专项储备 | 8,013,635.89 | 6,139,257.41 | 7,862,657.36 | 7,339,397.45 |
| 盈余公积 | 146,083,594 | 146,083,594 | 129,697,477.26 | 129,697,477.26 |
| 未分配利润 | 882,997,983.25 | 904,842,960.97 | 875,502,142.56 | 892,973,055.21 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,747,011,365.75 | 3,766,981,964.99 | 3,699,709,849.54 | 3,716,657,502.28 |
| 少数股东权益 | 66,416,332.35 | 65,172,189.02 | 62,314,602.25 | 78,836,710.92 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,813,427,698.1 | 3,832,154,154.01 | 3,762,024,451.79 | 3,795,494,213.2 |
| 负债和股东权益合计 | 5,471,384,233.67 | 5,604,990,741.71 | 5,603,939,876.88 | 5,737,806,131.82 |
| 公告日期 | 2025-04-29 | 2025-03-28 | 2024-10-25 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |